Emergent BioSolutions Inc. Form of Restricted Stock Unit Award AgreementRestricted Stock Unit Award Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Delaware
EMERGENT BIOSOLUTIONS INC. Form of Director Restricted Stock Unit AgreementRestricted Stock Unit Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Delaware
This Restricted Stock Unit Agreement is made as of the Agreement Date between Emergent BioSolutions Inc. (the “Company”), a Delaware corporation, and the Participant.
Form of Restricted Stock Unit Award Agreement – Canadian ParticipantRestricted Stock Unit Award Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Delaware
AMENDMENT NO. 1 TO LICENSE AGREEMENTLicense Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations
This Amendment No. 1 to License Agreement (this “Amendment”) is made as of December 13, 2016, by and among Opiant Pharmaceuticals Inc. (formerly known as Lightlake Therapeutics Inc.), a Nevada corporation (“Opiant”), and Adapt Pharma Operations Limited, an Irish limited company (“Adapt”). Opiant and Adapt are sometimes referred to herein individually as a “Party” and collectively as the “Parties”. Capitalized terms used but not defined herein have the meanings given to them in the License Agreement (as defined below).
Non-Qualified Stock Option Award Agreement – Irish ParticipantQualified Stock Option Award Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations
Form of UK Restricted Stock Unit Award Agreement – UK ParticipantRestricted Stock Unit Award Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Delaware
Non-Qualified Stock Option Award AgreementNon-Qualified Stock Option Award Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations
LICENSE AGREEMENT between LIGHTLAKE THERAPEUTICS INC. and ADAPT PHARMA OPERATIONS LIMITED Dated as of December 15, 2014License Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations • New York
This License Agreement (the “Agreement”) is made and entered into effective as of December 15, 2014 (the “Effective Date”) by and between Lightlake Therapeutics Inc., a Nevada corporation (“Lightlake”), and Adapt Pharma Operations Limited, an Irish limited company (“Adapt”). Lightlake and Adapt are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
Non-Qualified Stock Option Award Agreement – Swiss ParticipantQualified Stock Option Award Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations
Form of Restricted Stock Unit Award Agreement – Irish ParticipantRestricted Stock Unit Award Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Delaware
Non-Qualified Stock Option Award Agreement – Canadian ParticipantQualified Stock Option Award Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations
Non-Qualified UK Stock Option Award Agreement – UK ParticipantStock Option Award Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations
Form of Director Nonstatutory Stock Option AgreementStock Option Agreement • February 22nd, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations
